JavaScript is disabled for your browser. Some features of this site may not work without it.
We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
| dc.contributor.author | Omar, Shaheed Vally
|
|
| dc.contributor.author | Joseph, Lavania
|
|
| dc.contributor.author | Halima M. Said
|
|
| dc.contributor.author | Ismail, Farzana
|
|
| dc.contributor.author | Ismail, Nabila
|
|
| dc.contributor.author | Gwala, Thabisile L.
|
|
| dc.contributor.author | Ismail, Nazir Ahmed
|
|
| dc.date.accessioned | 2020-06-15T10:09:07Z | |
| dc.date.available | 2020-06-15T10:09:07Z | |
| dc.date.issued | 2019-02-21 | |
| dc.description.abstract | South Africa remains challenged with a high tuberculosis burden accompanied by an increase in drug resistant cases. We assessed the use of the Illumina MiSeq, a next-generation sequencing platform for whole genome sequencing, followed by bioinformatic analysis using a commercial software package to determine resistance to selected drugs used for Mycobacterium tuberculosis treatment in our setting. Whole genome sequencing shows potential as a diagnostic platform for the detection of drug resistance in Mycobacterium tuberculosis with the provision of information for several drugs simultaneously. | en_ZA |
| dc.description.department | Medical Microbiology | en_ZA |
| dc.description.librarian | am2020 | en_ZA |
| dc.description.sponsorship | Funding was provided by the National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa. | en_ZA |
| dc.description.sponsorship | The National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa | en_ZA |
| dc.description.uri | http://www.ajlmonline.org | en_ZA |
| dc.identifier.citation | Omar SV, Joseph L, Said HM, et al. Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis. African Journal of Laboratory Medicine 2019;8(1), a801. https://DOI.org/10.4102/ajlm.v8i1.801. | en_ZA |
| dc.identifier.issn | 2225-2002 (print) | |
| dc.identifier.issn | 2225-2010 (online) | |
| dc.identifier.other | 10.4102/ajlm.v8i1.801 | |
| dc.identifier.uri | http://hdl.handle.net/2263/74994 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | AOSIS Open Journals | en_ZA |
| dc.rights | © 2019. The Authors. Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. | en_ZA |
| dc.subject | Treatment | en_ZA |
| dc.subject | Whole genome sequencing | en_ZA |
| dc.subject | Mycobacterium tuberculosis (MTB) | en_ZA |
| dc.subject | Tuberculosis (TB) | en_ZA |
| dc.subject | South Africa (SA) | en_ZA |
| dc.subject | Drug resistance | en_ZA |
| dc.title | Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis | en_ZA |
| dc.type | Article | en_ZA |
